Home
About
Overview
Sharing Data
ORCID
Help
History (10)
In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance.
I. Arginine.
Effect of oral bethanechol on parameters of esophageal peristalsis.
Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial.
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract. 2009 Apr; 63(4):656-66.
View in:
PubMed
subject areas
Angiotensin Receptor Antagonists
Antihypertensive Agents
Cardiovascular Diseases
Clinical Trials as Topic
Diabetes Mellitus, Type 2
Humans
Life Style
Obesity
Renin-Angiotensin System
Risk Factors
Treatment Outcome
authors with profiles
Jan N. Basile